When will Belsomra (suvorexant) become generic?
Belsomra’s generic entry timing depends on when relevant patents and other exclusivity end for suvorexant in the specific market (for example, the US). The exact date isn’t provided in the information available here, so I can’t confirm the day it will become generic.
Why the generic date can vary (and what to check)
Generic drugs usually arrive after legal protections for the branded product run out. The key dates you’d typically look for are:
- Patent expiration (including any drug-substance, drug-product, or method-of-use patents covering suvorexant)
- Regulatory exclusivity that may delay approval or launch of generic versions
- Whether a generic manufacturer is authorized to launch immediately at first eligibility or later due to litigation or settlement
What to look up to get the exact date for your country
If you tell me your country (US, UK, EU, Canada, etc.), I can help you pinpoint the sources to check for the exact expected generic-availability date, such as patent registers and regulator drug-approval databases.
Will “generic” be available right away for every strength?
Even when generics become eligible, supply can roll out unevenly by strength and dosage form. Some manufacturers launch first in certain strengths or pack sizes, then expand.
If you want, I can narrow it down
Which country are you asking about (and what strength of Belsomra, if you know it)?